J. Moore

Methotrexate therapy for squamous cell carcinomas of the head and neck. Intermittent intravenous dose program.

H. Levin, F. E. Smith, M. Lane, 1968, JAMA.

Low-dose cyclophosphamide and low-dose interleukin-2 for malignant melanoma.

W. Boswell, R. Kempf, H. Shau, 1989, Bulletin of the New York Academy of Medicine.

Early high dose chemotherapy intensification with autologous bone marrow transplantation in lymphoma associated with retention of fertility and normal pregnancies in females. Scotland and Newcastle Lymphoma Group, UK.

G. Jackson, P. Robinson, A. Lennard, 1997, Leukemia & lymphoma.

Patient education for self-referral and on-demand treatment for herpes zoster in lymphoma patients.

P. Robinson, H. Lucraft, R. Evans, 1993, Leukemia & lymphoma.

P90: LANADELUMAB EFFICACY AND SAFETY REGARDLESS OF BASELINE ATTACK RATE IN PATIENTS WITH PREVIOUS LONG‐TERM PROPHYLAXIS OF HEREDITARY ANGIOEDEMA: A POST HOC SUBANALYSIS OF HELP OLE

Louise, A. Kelleher, E. Deenick, 2022 .

Targeting the BRAF pathway in haematological diseases

M. Dickinson, J. Seymour, A. Grigg, 2023, Internal medicine journal.

Rates of Menstrual History-Taking and Counseling With Anticancer Treatments Are Low: People Who Menstruate Deserve Gender-Specific Cancer Care.

A. Anazodo, Verity L Chadwick, R. Dear, 2023, Journal of the National Comprehensive Cancer Network : JNCCN.

International phase 3 study of azacitidine vs conventional care regimens in older patients with newly diagnosed AML with >30% blasts.

R. Greil, H. Döhner, M. Minden, 2015, Blood.

Efficacy of bortezomib, cyclophosphamide and dexamethasone in cardiac AL amyloidosis

K. Muthiah, P. Macdonald, C. Hayward, 2022, Internal medicine journal.